Guide

GLP-1s alone won't fix obesity. Here's what will.

Partner Insights from
Thank you for your interest. You can now access the asset below.
{download_button}


Welcome back.
You have registered as {email}. .

{download_button}

REGISTER NOW

The latest generation of GLP-1 and weight-management medications can deliver meaningful weight loss, but employers face real obstacles when demand surges: soaring utilization and costs, limited access to experienced obesity specialists, and the reality that medication alone doesn't address the behaviors and barriers needed for long-term success.

This whitepaper highlights key components for building comprehensive, sustainable obesity benefit strategies that reduce financial risk and support long-term employee health. By leading with behavior change, prioritizing personalization and tailored medication management, and leveraging better clinical support, employers stand to gain far better long-term outcomes.

You'll gain a clear framework for evaluating partners and programs and GLP-1 strategies that drive outcomes and protect the bottom line—along with insights from our employer pulse survey on what employees really want from their benefits and a companion infographic on tackling the cost of chronic conditions.